stella
beta
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML — Stella
Home
/
AML, Childhood
/
View on ClinicalTrials.gov
Recruiting
Back to AML, Childhood trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(13 sites)
China
First Affiliated Hospital Of University of Science and Technology of China, Hefei, Anhui
The Second Hospital of Anhui Medical University, Hefei, Anhui
Guangzhou Women and Children Medical Center, Guangzhou, Guangdong
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi
Kaifeng Children's Hospital, Kaifeng, Henan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
Third Xiangya Hospital of Central South University, Changsha, Hunan
XiangYa Hospital Central South University, Changsha, Hunan
Children's Hospital of Soochow University, Suzhou, Jiangsu
Xuzhou Children's Hospital, Xuzhou, Jiangsu
Qilu Hospital of Shandong University, Jinan, Shandong
Children's Hospital Of Fudan University, Shanghai, Shanghai Municipality
Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing